MPO has been reported to contribute to the development of CAD through multiple pathways, including triggering endothelial dysfunction, activation of inflammatory responses and weakening of atherosclerotic plaques (Chaikijurajai and Tang, 2020). This evidence concerns the gene MPO and endothelial dysfunction.